Targeting a specific enzyme to treat Alzheimer's disease
Official title: Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease
Funded at University of Texas Hlth Science Center · NIH-10633381 · Data updated 2026-11-12
This study is exploring a new way to help people with Alzheimer's by targeting a specific enzyme in brain cells to reduce inflammation, which could slow down the disease and improve thinking skills.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | April 15, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $2,278,287 |
| NIH project number | 1RF1AG081362-01 |
| Project ID | NIH-10633381 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or those at risk of developing it.
✕Less likely to help
Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
What this research studies
This research investigates a new approach to treating Alzheimer's disease by focusing on a specific enzyme called monoacylglycerol lipase (MAGL). The study aims to selectively inhibit MAGL in astrocytes, which are supportive cells in the brain, to reduce neuroinflammation and potentially slow the progression of Alzheimer's. By understanding how this enzyme affects the brain's inflammatory response, the research seeks to develop a targeted therapy that could improve cognitive function in patients. The methodology involves both laboratory studies and animal models to assess the effectiveness and safety of this treatment strategy.
Why it matters
Potential benefit: If successful, this research could lead to a novel therapy that slows the progression of Alzheimer's disease and improves the quality of life for patients.
How similar studies have gone: Previous studies have shown promise in targeting MAGL for neurodegenerative diseases, indicating potential success for this approach.
Where this research is happening
-
University of Texas Hlth Science Center
San Antonio, United States Active
Researchers
- Principal investigator: Chen, Chu — University of Texas Hlth Science Center
- Study coordinator: Chen, Chu
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.